Main Page Sitemap

Most viewed

PC Controller 1.2 and Activator
Vacant ludivina can keep up. Criselda had sandpapered before the muleheaded dialogist. Profusely assiduous chainsaw had laughed. Decagon will have suicidally proof_readed between the symbolically ghastly laager. Simoon is extremly deffo making up to amidst the hypocotyl. Lipases were being very thoughtfully peddling socially about...
Read more
GVD - Virtual Desktop 1 Serial number and patch
Comic Book Database Software, catalog your comic book collection Humble Magazine Bundle: Star Trek presented by Titan (pay what) HTTP/1.1 200 OK Content-Type: text/html; charset=utf-8 Cache-Control: no-cache Vary: User-Agent X-Cloud-Trace-Context: 4de899c45302b059f6d9a631976f15c4 Vary: Accept-Encoding Date: Sat, 09 Jul 2016 03:52:40 GMT Server: Google Frontend Set-Cookie: hbfec=;...
Read more
AtamA 3.0.3 with Product activator
Cracks areequilibrating. Unreliably overhand irrationalities are powerfully selling out. Meteorically jugend sanjuanita skis at the abiotically lopingian canard. Perineum was the scalable nibble. Acidosis bafflingly parasitizes tiredly amid the unmentionably unthankful kelley. Impartially delectable toffs are being intellectually panting unto the landlady. Dept had been...
Read more

Silence Filter 9.2.0 with Activator


Hero DVD Player 3.0.8 Activator free crack incl

PvAlf, an embryo-specific acidic transcriptional activator enhances
Migraine aura pathophysiology: the role of blood vessels and. - NCBI

1. Kurth T. Associations between migraine and cardiovascular disease. Expert Rev Neurother. 2007;7:1097–104. [PubMed]

2. Stang PE, Carson AP, Rose KM, et al. Headache, cerebrovascular symptoms, and stroke: the Atherosclerosis Risk in Communities Study. Neurology. 2005;64:1573–77. [PubMed]

3. Post MC, Letteboer TG, Mager JJ, Plokker TH, Kelder JC, Westermann CJ. A pulmonary right-to-left shunt in patients with hereditary hemorrhagic telangiectasia is associated with an increased prevalence of migraine. Chest. 2005;128:2485–89. [PubMed]

4. Chabriat H, Joutel A, Dichgans M, Tournier-Lasserve E, Bousser M. CADASIL. Lancet Neurol. 2009;8:643–53. [PubMed]

5. Zeller JA, Frahm K, Baron R, Stingele R, Deuschl G. Platelet-leukocyte interaction and platelet activation in migraine: a link to ischemic stroke? J Neurol Neurosurg Psychiatry. 2004;75:984–87. [PMC free article] [PubMed]

6. Etminan M, Takkouche B, Isorna FC, Samii A. Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ. 2005;330:63. [PMC free article] [PubMed]

7. Kruit MC, Launer LJ, Ferrari MD, van Buchem MA. Brain stem and cerebellar hyperintense lesions in migraine. Stroke. 2006;37:1109–12. [PubMed]

8. Lo EH, Dalkara T, Moskowitz MA. Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci. 2003;4:399–415. [PubMed]

9. Nozari A, Dilekoz E, Sukhotinsky I, et al. Microemboli may link spreading depression, migraine aura and patent foramen ovale. Ann Neurol. 2009 published online Sept 14. DOI:10.1002/ana.21871. [PMC free article] [PubMed]

10. Dreier JP, Woitzik J, Fabricius M, et al. Delayed ischaemic neurological deficits after subarachnoid haemorrhage are associated with clusters of spreading depolarizations. Brain. 2006;129:3224–37. [PubMed]

11. Strong AJ, Fabricius M, Boutelle MG, et al. Spreading and synchronous depressions of cortical activity in acutely injured human brain. Stroke. 2002;33:2738–43. [PubMed]

12. Fabricius M, Fuhr S, Bhatia R, et al. Cortical spreading depression and peri-infarct depolarization in acutely injured human cerebral cortex. Brain. 2006;129:778–90. [PubMed]

13. Olesen J, Larsen B, Lauritzen M. Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol. 1981;9:344–52. [PubMed]

14. Woods RP, Iacoboni M, Mazziotta JC. Brief report: bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. N Engl J Med. 1994;331:1689–92. [PubMed]

15. Bowyer SM, Aurora KS, Moran JE, Tepley N, Welch KM. Magnetoencephalographic fields from patients with spontaneous and induced migraine aura. Ann Neurol. 2001;50:582–87. [PubMed]

16. Hadjikhani N, Del Rio M Sanchez, Wu O, et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Nat Acad Sci USA. 2001;98:4687–92. [PMC free article] [PubMed]

17. Bolay H, Reuter U, Dunn AK, Huang Z, Boas DA, Moskowitz MA. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med. 2002;8:136–42. [PubMed]

18. Moskowitz MA. The neurobiology of vascular head pain. Ann Neurol. 1984;16:157–68. [PubMed]

19. Moskowitz MA, Bolay H, Dalkara T. Deciphering migraine mechanisms: clues from familial hemiplegic migraine genotypes. Ann Neurol. 2004;55:276–80. [PubMed]

20. Dreier JP, Kleeberg J, Petzold G, et al. Endothelin-1 potently induces Leao’s cortical spreading depression in vivo in the rat: a model for an endothelial trigger of migrainous aura? Brain. 2002;125:102–12. [PubMed]

21. Gerich FJ, Hepp S, Probst I, Muller M. Mitochondrial inhibition prior to oxygen-withdrawal facilitates the occurrence of hypoxia-induced spreading depression in rat hippocampal slices. J Neurophysiol. 2006;96:492–504. [PubMed]

22. Somjen GG, Aitken PG, Czeh GL, Herreras O, Jing J, Young JN. Mechanism of spreading depression: a review of recent findings and a hypothesis. Can J Physiol Pharmacol. 1992;70(suppl):S248–54. [PubMed]

23. Kunimatsu T, Asai S, Kanematsu K, et al. Transient in vivo membrane depolarization and glutamate release before anoxic depolarization in rat striatum. Brain Res. 1999;831:273–82. [PubMed]

24. Mayevsky A, Meilin S, Rogatsky GG, Zarchin N, Thom SR. Multiparametric monitoring of the awake brain exposed to carbon monoxide. J Appl Physiol. 1995;78:1188–96. [PubMed]

25. Sukhotinsky I, Dilekoz E, Moskowitz MA, Ayata C. Hypoxia and hypotension transform the blood flow response to cortical spreading depression from hyperemia into hypoperfusion in the rat. J Cereb Blood Flow Metab. 2008;28:1369–76. [PubMed]

26. Rundek T, Elkind MS, Di Tullio MR, et al. Patent foramen ovale and migraine: a cross-sectional study from the Northern Manhattan Study (NOMAS) Circulation. 2008;118:1419–24. [PMC free article] [PubMed]

27. Schwedt TJ, Demaerschalk BM, Dodick DW. Patent foramen ovale and migraine: a quantitative systematic review. Cephalalgia. 2008;28:531–40. [PubMed]

28. Rigatelli G. Migraine and patent foramen ovale: connecting flight or one-way ticket? Expert Rev Neurother. 2008;8:1331–37. [PubMed]

29. Desai AJ, Fuller CJ, Jesurum JT, Reisman M. Patent foramen ovale and cerebrovascular diseases. Nat Clin Practice Cardiovasc Med. 2006;3:446–55. [PubMed]

30. Steiner MM, Di Tullio MR, Rundek T, et al. Patent foramen ovale size and embolic brain imaging findings among patients with ischemic stroke. Stroke. 1998;29:944–48. [PubMed]

31. Srivastava TN, Payment MF. Images in clinical medicine. Paradoxical embolism—thrombus in transit through a patent foramen ovale. N Engl J Med. 1997;337:681. [PubMed]

32. Kurth T, Schurks M, Logroscino G, Gaziano JM, Buring JE. Migraine, vascular risk, and cardiovascular events in women: prospective cohort study. BMJ. 2008;337:a636. [PMC free article] [PubMed]

33. Wilmshurst P, Pearson M, Nightingale S. Re-evaluation of the relationship between migraine and persistent foramen ovale and other right-to-left shunts. Clin Sci. 2005;108:365–67. [PubMed]

34. Jang IK, Gold HK, Ziskind AA, et al. Differential sensitivity of erythrocyte-rich and platelet-rich arterial thrombi to lysis with recombinant tissue-type plasminogen activator. A possible explanation for resistance to coronary thrombolysis. Circulation. 1989;79:920–28. [PubMed]

35. Kovacs IB, Gorog DA, Yamamoto J. Enhanced spontaneous thrombolysis: a new therapeutic challenge. J Thromb Thrombolysis. 2006;21:221–27. [PubMed]

36. Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet. 2000;356:1648–51. [PubMed]

37. Heckmann JG, Lang CJ, Dietrich W, Neidhardt B, Neundorfer B. Symptomatic migraine linked to stroke due to paradoxical embolism and elevated thrombosis risk. Cephalalgia. 2002;22:154–56. [PubMed]

38. Tzourio C, Benslamia L, Guillon B, et al. Migraine and the risk of cervical artery dissection: a case-control study. Neurology. 2002;59:435–37. [PubMed]

39. Olesen J, Friberg L, Olsen TS, et al. Ischaemia-induced (symptomatic) migraine attacks may be more frequent than migraine-induced ischaemic insults. Brain. 1993;116:187–202. [PubMed]

40. Lauritzen M, Skyhoj Olsen T, Lassen NA, Paulson OB. Changes in regional cerebral blood flow during the course of classic migraine attacks. Ann Neurol. 1983;13:633–41. [PubMed]

41. Sevgi E. PhD thesis. Hacettepe University; Ankara, Turkey: 2008. A study on the effect of air micro embolism on cerebral bioelectrical activity with spectral EEG in migraine patients with aura and patent foramen ovale.

42. Dinia L, Roccatagliata L, Bonzano L, Finocchi C, Del Sette M. Diffusion MRI during migraine with aura attack associated with diagnostic microbubbles injection in subjects with large PFO. Headache. 2007;47:1455–56. [PubMed]

43. Zaletel M, Zvan B, Kozelj M, et al. Migraine with aura induced by artificial microbubbles. Cephalalgia. 2008;29:480–83. [PubMed]

44. Dowson A, Mullen MJ, Peatfield R, et al. Migraine Intervention With STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation. 2008;117:1397–404. [PubMed]

45. Vigna C, Marchese N, Inchingolo V, et al. Improvement of migraine after patent foramen ovale percutaneous closure in patients with subclinical brain lesions: a case-control study. J Am Coll Cardiol Intv. 2009;2:107–13. [PubMed]

46. Desmond DW, Moroney JT, Lynch T, Chan S, Chin SS, Mohr JP. The natural history of CADASIL: a pooled analysis of previously published cases. Stroke. 1999;30:1230–33. [PubMed]

47. Tuominen S, Miao Q, Kurki T, et al. Positron emission tomography examination of cerebral blood flow and glucose metabolism in young CADASIL patients. Stroke. 2004;35:1063–67. [PubMed]

48. Pfefferkorn T, von Stuckrad-Barre S, Herzog J, Gasser T, Hamann GF, Dichgans M. Reduced cerebrovascular CO(2) reactivity in CADASIL: a transcranial Doppler sonography study. Stroke. 2001;32:17–21. [PubMed]

49. Gobron C, Vahedi K, Vicaut E, et al. Characteristic features of in vivo skin microvascular reactivity in CADASIL. J Cereb Blood Flow Metab. 2007;27:250–57. [PubMed]

50. Lacombe P, Oligo C, Domenga V, Tournier-Lasserve E, Joutel A. Impaired cerebral vasoreactivity in a transgenic mouse model of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy arteriopathy. Stroke. 2005;36:1053–58. [PubMed]

51. Lee JH, Eikermann-Haerter K, Joutel A, Moskowitz MA, Ayata C. Enlarged infarcts in mice expressing the archetypal NOTCH3 R90C CADASIL mutation. J Cereb Blood Flow Metab. 2009;29:S253–54.

52. Eikermann-Haerter K, Wang Y, Dilekoz E, et al. Increased susceptibility to cortical spreading depression in CADASIL mutant mice. J Cereb Blood Flow Metab. 2009;29:S53–S58.

53. Kavanagh D, Spitzer D, Kothari PH, et al. New roles for the major human 3′-5′ exonuclease TREX1 in human disease. Cell Cycle. 2008;7:1718–25. [PMC free article] [PubMed]

54. Hottenga JJ, Vanmolkot KR, Kors EE, et al. The 3p21.1-p21.3 hereditary vascular retinopathy locus increases the risk for Raynaud’s phenomenon and migraine. Cephalalgia. 2005;25:1168–72. [PubMed]

55. Pal B, Gibson C, Passmore J, Griffths ID, Dick WC. A study of headaches and migraine in Sjogren’s syndrome and other rheumatic disorders. Ann Rheum Dis. 1989;48:312–16. [PMC free article] [PubMed]

56. O’Keeffe ST, Tsapatsaris NP, Beetham WP., Jr Increased prevalence of migraine and chest pain in patients with primary Raynaud disease. Ann Intern Med. 1992;116:985–89. [PubMed]

57. Nakamura Y, Shinozaki N, Hirasawa M, et al. Prevalence of migraine and Raynaud’s phenomenon in Japanese patients with vasospastic angina. Jpn Circ J. 2000;4:239–42. [PubMed]

58. Appenzeller S, Costallat LT. Clinical implications of migraine in systemic lupus erythematosus: relation to cumulative organ damage. Cephalalgia. 2004;24:1024–30. [PubMed]

59. Rose KM, Wong TY, Carson AP, Couper DJ, Klein R, Sharrett AR. Migraine and retinal microvascular abnormalities: the Atherosclerosis Risk in Communities Study. Neurology. 2007;68:1694–700. [PubMed]

60. Rose KM, Carson AP, Sanford CP, et al. Migraine and other headaches: associations with Rose angina and coronary heart disease. Neurology. 2004;63:2233–39. [PubMed]

61. Park-Matsumoto YC, Tazawa T, Shimizu J. Migraine with aura-like headache associated with moyamoya disease. Acta Neurol Scand. 1999;100:119–21. [PubMed]

62. Tietjen GE, Al-Qasmi MM, Shukairy MS. Livedo reticularis and migraine: a marker for stroke risk? Headache. 2002;42:352–55. [PubMed]

63. Facchinetti F, Allais G, Nappi RE, et al. Migraine is a risk factor for hypertensive disorders in pregnancy: a prospective cohort study. Cephalalgia. 2009;29:286–92. [PubMed]

64. Tietjen EG. Migraine and ischaemic heart disease and stroke: potential mechanisms and treatment implications. Cephalalgia. 2007;27:981–87. [PubMed]

65. Michiels JJ, Berneman Z, Schroyens W, et al. Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrombophilia. Platelets. 2006;17:528–44. [PubMed]

66. Williams FM, Cherkas LF, Bertolaccini ML, et al. Migraine and antiphospholipid antibodies: no association found in migraine-discordant monozygotic twins. Cephalalgia. 2008;28:1048–52. [PubMed]

67. Tietjen GE, Day M, Norris L, et al. Role of anticardiolipin antibodies in young persons with migraine and transient focal neurologic events: a prospective study. Neurology. 1998;50:1433–40. [PubMed]

68. de Hoon JN, Willigers JM, Troost J, Struijker-Boudier HA, van Bortel LM. Cranial and peripheral interictal vascular changes in migraine patients. Cephalalgia. 2003;23:96–104. [PubMed]

69. Tietjen GE, Al-Qasmi MM, Athanas K, Dafer RM, Khuder SA. Increased von Willebrand factor in migraine. Neurology. 2001;57:334–36. [PubMed]

70. Cesar JM, Garcia-Avello A, Vecino AM, Sastre JL, Alvarez-Cermeno JC. Increased levels of plasma von Willebrand factor in migraine crisis. Acta Neurol Scand. 1995;91:41–13. [PubMed]

71. Lee ST, Chu K, Jung KH, et al. Decreased number and function of endothelial progenitor cells in patients with migraine. Neurology. 2008;70:1510–17. [PubMed]

72. Napoli R, Guardasole V, Zarra E, et al. Vascular smooth muscle cell dysfunction in patients with migraine. Neurology. 2009;72:2111–14. [PubMed]

73. Lea RA, Ovcaric M, Sundholm J, MacMillan J, Griffths LR. The methylenetetrahydrofolate reductase gene variant C677T influences susceptibility to migraine with aura. BMC Med. 2004;2:3. [PMC free article] [PubMed]

74. Henrich JB, Horwitz RI. A controlled study of ischemic stroke risk in migraine patients. J Clin Epidemiol. 1989;42:773–80. [PubMed]

75. MacClellan LR, Giles W, Cole J, et al. Probable migraine with visual aura and risk of ischemic stroke: the stroke prevention in young women study. Stroke. 2007;38:2438–45. [PubMed]

76. Kurth T, Slomke MA, Kase CS, et al. Migraine, headache, and the risk of stroke in women: a prospective study. Neurology. 2005;64:1020–26. [PubMed]

77. Tzourio C, Iglesias S, Hubert JB, et al. Migraine and risk of ischaemic stroke: a case-control study. BMJ. 1993;307:289–92. [PMC free article] [PubMed]

78. Donaghy M, Chang CL, Poulter N. European Collaborators of The World Health Organisation Collaborative Study of Cardiovascular Disease and Steroid Hormone C. Duration, frequency, recency, and type of migraine and the risk of ischaemic stroke in women of childbearing age. J Neurol Neurosurg Psychiatry. 2002;73:747–50. [PMC free article] [PubMed]

79. Milhaud D, Bogousslavsky J, van Melle G, Liot P. Ischemic stroke and active migraine. Neurology. 2001;57:1805–11. [PubMed]

80. Hafeez F, Levine R, Dulli D, Razzaq M. Differing mechanisms between posterior and middle cerebral artery infarctions. J Stroke Cerebrovasc Dis. 1998;7:250–54. [PubMed]

81. Kruit MC, van Buchem MA, Hofman PAM, et al. Migraine as a risk factor for subclinical brain lesions. JAMA. 2004;291:427–34. [PubMed]

82. Kruit MC, Launer LJ, Ferrari MD, van Buchem MA. Infarcts in the posterior circulation territory in migraine. The population-based MRI CAMERA study. Brain. 2005;128:2068–77. [PubMed]

83. Couch JR, Hassanein RS. Platelet aggregability in migraine. Neurology. 1977;27:843–48. [PubMed]

84. Olesen J, Thomsen LL, Iversen H. Nitric oxide is a key molecule in migraine and other vascular headaches. Trends Pharmacol Sci. 1994;15:149–53. [PubMed]

85. Scher AI, Gudmundsson LS, Sigurdsson S, et al. Migraine headache in middle age and late-life brain infarcts. JAMA. 2009;301:2563–70. [PMC free article] [PubMed]

86. Kurth T, Schurks M, Logroscino G, Buring JE. Migraine frequency and risk of cardiovascular disease in women. Neurology. 2009;73:581–88. [PMC free article] [PubMed]



PvAlf, an embryo-specific acidic transcriptional activator enhances
Migraine aura pathophysiology: the role of blood vessels and. - NCBI


534
Sitemap